Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Management of Heart Failure with Hypotension

Immediate Assessment and Stabilization

  • The American College of Cardiology recommends immediate assessment for cardiogenic shock and rapid intervention to restore systemic perfusion while addressing volume overload, starting with a fluid challenge if no overt fluid overload is present, followed by inotropic support if hypoperfusion persists, and initiate IV loop diuretics cautiously once perfusion is stabilized 1, 2, 3
  • Key clinical signs to assess immediately include signs of hypoperfusion, such as altered mental status, cold extremities, oliguria, lactate >2 mmol/L, and metabolic acidosis, as well as signs of elevated filling pressures, including elevated jugular venous pressure, pulmonary crackles, and peripheral edema 2, 3, 4
  • Oxygen saturation should be maintained above 90% with supplemental oxygen 4

Initial Monitoring and Testing

  • The European Society of Cardiology recommends establishing invasive monitoring immediately, including arterial line for continuous blood pressure monitoring, continuous ECG monitoring, pulse oximetry, and respiratory rate, as well as urine output monitoring 1, 3, 4
  • Urgent diagnostic studies should be obtained, including ECG to exclude ST-elevation myocardial infarction, echocardiography to assess cardiac function and filling pressures, laboratory tests for electrolytes, renal function, lactate, and natriuretic peptides, and chest X-ray 1, 3, 4, 5

Treatment Algorithm Based on Clinical Presentation

  • For patients with hypotension and signs of hypoperfusion, the American College of Cardiology recommends a fluid challenge first, followed by inotropic support if hypoperfusion persists, and consideration of invasive hemodynamic monitoring with pulmonary artery catheter to guide therapy 1, 2, 3
  • Dobutamine is the preferred inotrope to increase cardiac output, while levosimendan may be considered, especially if the patient is on chronic beta-blockers, and vasopressors, such as norepinephrine, should only be used if there is a strict need to maintain systolic blood pressure in the presence of persistent hypoperfusion 3

Critical Medication Considerations

  • The American College of Cardiology recommends continuing guideline-directed medical therapy, including ACE inhibitors, ARBs, and beta-blockers, in the absence of hemodynamic instability or contraindications, but with caution and potential temporary dose reduction or holding if blood pressure is severely low 1, 2

Disposition and Monitoring

  • The European Society of Cardiology recommends ICU/CCU admission with continuous hemodynamic monitoring, serial assessment of fluid status, perfusion, and respiratory status, daily measurement of electrolytes and renal function, and careful fluid intake/output monitoring 1, 3, 4

REFERENCES